Celgene's second quarter results beat estimates and the company lifted 2018 outlook. Celgene will not be increasing the price of its products this year. https://news.alphastreet.com/celgene-q2-2018-earnings/
anonymous
Thread
alexion
allergan
celgene
donaldtrump
drug price
eli lilly
gilead
novartis
pfizer
sanofi
Investors have welcomed the move of Eli Lilly's decision to separate Elanco Animal Health business. Lilly stock hits a new 52-week high after the earnings announcement. David Ricks said, "As the responses to the Blueprint are considered, we are hopeful that progress will be made on implementing...
anonymous
Thread
biotech
david ricks
donaldtrump
drug price
elanco animal health
eli lilly
merck
novartis
pfizer
pharma
Trump has been speaking and tweeting about the higher drug prices for nearly two years and still he has not taken any steps in reducing the prices of the drugs. Pfizer and other pharma companies are taking advantage and increasing their drug prices often. When will this stop...